glp 1 drugs moa Glucagon-like peptide receptor agonists: cardiovascular benefits and mechanisms of action Consensus Recommendations on GLP-1 RA

For example, in March 2024, the Office for Health Improvement and Disparities, a UK-based government agency, reported that between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, while for type 2 diabetes, it rose by 21%

Propensity score adjustment was applied to account for baseline differences

Nat Prod Commun (2017) 12:1934578X1701200240

as a treatment for type 2 diabetes for several years, but they only recently made their way into national media headlines, largely due to their recent approval and use for weight loss

In contrast, saline-treated mice had FBG levels exceeding 20 mmol/L

Here, GLP-1RAs are one exciting option [28]